Absence of vasoactive properties of travoprost in isolated porcine ciliary arteries

被引:6
作者
Allemann, R [1 ]
Flammer, J [1 ]
Haefliger, IO [1 ]
机构
[1] Univ Eye Clin Basel, Lab Ocular Pharmacol & Physiol, CH-4012 Basel, Switzerland
关键词
latanoprost; ocular blood flow; glaucoma; intraocular pressure; prostaglandin; prostamide;
D O I
10.1055/s-2003-38169
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Ocular blood flow dysregulation is considered to be a risk factor associated with the optic neuropathy observed in glaucoma patients. The present study evaluates the vasoactive effect of the ocular hypotensive agent travoprost (Travatan(R)) on isolated pig ciliary arteries. Material and methods: Isometric forces were measured with a myograph system. Quiescent vessels were exposed in a cumulative manner to increasing concentrations (0.1 nM-0.1 mM) of travoprost ([+]-fluprostenol). Vessels pre-contracted with 100 mM potassium chloride (KCl) or 10 nM endothelin-1 were also exposed in a similar manner to travoprost. Time-control experiments without travoprost were always run in parallel. In quiescent vessels, contractions were expressed in percent of 100 mM KCl-induced contractions. In vessels pre-contracted with endothelin-1, relaxations were expressed in percent of the maximal contraction induced by this peptide, while in those pre-contracted with KCl, relaxations were expressed in percent of the plateau-contraction reached 30 minutes after the application of this drug. Results: In quiescent vessels, travoprost had no statistically significant vasoconstrictive effect. In KCl- or in endothelin-1 pre-contracted vessels, travoprost had no statistically significant vasorelaxing effect. Conclusions: Although the clinical relevance of the results of this study for patients treated with travoprost (Travatan(R)) needs to be further investigated, travoprost appears to have no vasoconstrictive properties in isolated porcine ciliary arteries.
引用
收藏
页码:152 / 155
页数:4
相关论文
共 17 条
[1]   Latanoprost is a vasoconstrictor in isolated porcine ciliary arteries [J].
Brogiolo, G ;
Flammer, J ;
Haefliger, IO .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2001, 218 (05) :373-375
[2]   Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure - A 6-month, masked, multicenter trial [J].
Fellman, RL ;
Sullivan, EK ;
Ratliff, M ;
Silver, LH ;
Whitson, JT ;
Turner, FD ;
Weiner, AL ;
Davis, AA .
OPHTHALMOLOGY, 2002, 109 (05) :998-1008
[3]  
Flammer J, 1999, J GLAUCOMA, V8, P212
[4]   The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow [J].
Georgopoulos, GT ;
Diestelhorst, M ;
Fisher, R ;
Ruokonen, P ;
Krieglstein, GK .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2002, 80 (01) :54-58
[6]   Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist [J].
Hellberg, MR ;
Sallee, VL ;
McLaughlin, MA ;
Sharif, NA ;
Desantis, L ;
Dean, TR ;
Zinke, PW .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (05) :421-432
[7]   Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma [J].
Kaiser, HJ ;
Schoetzau, A ;
Stumpfig, D ;
Flammer, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (03) :320-327
[8]   Eicosanoids in bovine retinal microcirculation [J].
Kulkarni, P ;
Payne, S .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1997, 13 (02) :139-149
[9]   Exacerbation of angina associated with latanoprost [J].
Mitra, M ;
Chang, B ;
James, T .
BRITISH MEDICAL JOURNAL, 2001, 323 (7316) :783-783
[10]   Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5% [J].
Orengo-Nania, S ;
Landry, T ;
Von Tress, M ;
Silver, LH ;
Weiner, A ;
Davis, AA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (06) :860-868